Sign in

CIK 0000907654

  • Non-accelerated filer
  • Smaller reporting company

Oruka Therapeutics, Inc.

Sign in to watch
Ticker
ORKA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
363855489
Phone
+1 650-606-7910
Business address
855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
Former names
ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
  1. 4 Open-market sale 10% owner sold 1,460,209 shares at $0.50 ($731,273)
  2. 4 Open-market sale 10% owner sold 1,460,209 shares at $0.50 ($731,273)
  3. 4 Open-market sale 10% owner sold 1,460,209 shares at $0.50 ($731,273)
  4. 4 Open-market sale 10% owner sold 1,460,209 shares at $0.50 ($731,273)
  5. 4 Open-market sale 10% owner sold 1,460,209 shares at $0.50 ($731,273)
  6. 4 Open-market sale 10% owner sold 1,460,209 shares at $0.50 ($731,273)
  7. 4 Open-market sale 10% owner sold 1,460,209 shares at $0.50 ($731,273)
  8. 4 Open-market sale 10% owner sold 1,460,209 shares at $0.50 ($731,273)
  9. 4 Open-market buy Director bought 10,000 shares at $2.49 ($24,900)
  10. 4 Open-market buy Director bought 11,000 shares at $2.71 ($29,810)
  11. 4 Open-market sale VP, Finance sold 1,114 shares at $2.46 ($2,740)
  12. 4 Open-market sale S.V.P., General Counsel sold 418 shares at $2.41 ($1,007)
  13. 4 Open-market sale Chief Operating Officer sold 390 shares at $2.41 ($940)
  14. 4 Open-market sale Pres. & Chief Executive Offic sold 720 shares at $2.41 ($1,735)
  15. 4 Open-market buy Director bought 25,000 shares at $2.59 ($64,750)
  16. 4 Open-market sale VP, Finance sold 161 shares at $2.56 ($412)
  17. 4 Open-market sale S.V.P., General Counsel sold 465 shares at $2.61 ($1,214)
  18. 4 Open-market sale Chief Operating Officer sold 465 shares at $2.61 ($1,214)
  19. 4 Open-market sale Pres. & Chief Executive Offic sold 763 shares at $2.61 ($1,991)
  20. 4 Derivatives Options or other derivatives

Page 9 of 23 · 459 filings